SUMMARY
Electroconvulsive therapy (ECT) is effective for the treatment of drug-therapy-resistant severe depression. Although short-acting barbiturates such as methohexitone and thiopentone are commonly used for the anaesthesia 1 , propofol at less than 1 mg/kg has also been recommended for ECT anaesthesia 2, 3 . Recent studies have demonstrated that systemic and cerebral haemodynamics during ECT are more stable under propofol anaesthesia than under barbiturate anaesthesia [2] [3] [4] [5] [6] . However, seizure duration tends to be shorter under propofol anaesthesia than under barbiturate or etomidate anaesthesia. Simpson et al reported that 1.3 mg/kg propofol is not acceptable for ECT because of excessively short seizure duration 7 . Avramov et al demonstrated that propofol, at doses greater than 1 mg/kg, causes a decrease of around 45% in ECT-induced seizure duration 3 . Although the view that seizure duration is a primary determinant of treatment efficacy is changing, seizure durations of less than 25 s 8 or 15 s 9 are still believed to be less effective. Propofol less than 1 mg/kg may ensure longer seizures, but some patients can not be anaesthetized by the low dose propofol 10 . The level of hypnosis in ECT patients after injection of propofol at a fixed dose is not necessarily identical among subjects. In our previous report we demonstrated that anaesthesia depth assessed by bispectral index score (BIS) was variable among ECT patients who received identical doses (per weight) of propofol. Also, we reported that there was a positive correlation among patients between seizure duration and BIS value immediately before electrical stimulus 11 . Recently, White et al found similar results during ECT under methohexitone anaesthesia 12 . These results suggest that in patients whose seizure duration is short, the effects of propofol are greater than in those patients with longer seizure durations. This may be due to either pharmacokinetic or pharmacodynamic characteristics of propofol in these patients.
When seizure duration in an ECT treatment is considered to be short, adjustment of anaesthesia depth according to BIS values in the following treatment may be effective in obtaining more prolonged seizures. In the present study, we examined this hypothesis in the second and third ECT treatments. Patients whose seizure had been greater than 40 s in the second ECT treatment were excluded as subjects, because psychiatrists did not require longer seizures. A secondary aim was to examine haemodynamic effects of electrical stimulation under the different conditions.
METHODS
Written informed consent was obtained from the patients, or where necessary, the appropriate relative. The study protocol was approved by our Hospital Clinical Study Committee, which considers the ethics and legal aspects of clinical investigations. This study was prospective but non-randomized. Data were obtained from 20 consecutive patients who were prescribed ECT for treatment of endogenous depression. All patients were treated more than six times (three times per week at two-day intervals). The data were obtained in the second and third ECT treatments in each case.
Atropine 0.01 mg/kg IM was given as premedication. Arterial blood pressure (BP) was measured continuously at the right radial artery using a tonometric BP monitor (CBM-7000; Colin Co. Ltd., Komaki, Japan). The BIS (model A-1050, Bios Ver 3.050, rev 1.30; Aspect Medical Systems, Natick MA) electrode (Aspect™, 186-0100; Natick MA) was attached to the forehead of the patients as per manufacturer's instructions. Single-lead electroencephalography (EEG) was recorded on the same monitor. General anaesthesia was induced with propofol 1 mg/kg. Propofol was administered over 15 seconds through an indwelling IV catheter. After loss of consciousness, succinylcholine chloride (1 mg/kg) was administered and ventilation was assisted using a facemask and 100% oxygen. The effect of succinylcholine chloride was confirmed by a muscle relaxation monitor (TOFwatch SX: Organon, Swords, Ireland). The electroshock stimulus was delivered bilaterally by a trained psychiatrist using an ECT stimulator (THYMATRON™ DGx; Somatics Inc. Pleasanton, CA).
In the first ECT treatment, the stimulus intensity was determined by a stepwise increasing method at 60 s after the propofol injection. The efficacy of electrical stimulation was determined using a tourniquet technique (i.e. by observation of convulsive movements of the distal leg, around which an inflated tourniquet was set to prevent the distribution of muscle relaxant). EEG seizure duration was also measured by an EEG monitor set in the electrical stimulator. The end-tidal CO 2 partial pressure (ETCO 2 ) at the nostrils and the arterial blood oxygen saturation (SpO 2 ) were monitored by a respiration monitor (Capnomac Ultima; Datex Co. Ltd., Helsinki, Finland). End-tidal CO 2 was maintained at 30 to 35 mmHg and the SpO 2 value above 98% by manual ventilation assistance throughout the therapy.
When patients had a muscular seizure shorter than 40 s in the second treatment, the patient received electrical stimulation after a 10 to 20% recovery in BIS value in the third treatment. The other conditions in the second and the third treatment were identical. In all cases we ensured that the BIS at which stimulation occurred was lower than the BIS at which patients lost consciousness after their initial bolus of propofol.
The data for blood pressure, heart rate and seizure durations are expressed as mean±SD. These data were compared by one-way analysis of variance with Scheffe's post-hoc test (Stat View 5.0, SAS Institute Inc., NC). BIS values are expressed as median and range, and were statistically compared by a MannWhitney U test. A P value <0.05 was considered statistically significant.
RESULTS
Demographics of the patients in this study were as follows: 62±15 years of age, 156±14 cm height, 52±15 kg weight. The patients ranged from 22 to 80 years of age and were in good physical heath (ASA physical status 1-2). The patients had received multiple psychiatric medications at various doses previously. However, they were not responsive to drug therapies, and these medications were interrupted at least one day before the start of ECT sessions. All patients could be anaesthetized by the single bolus injection of propofol at 1 mg/kg. During this study period there was no patient excluded from data collection. Intensity of stimulus was 37±13%. Intensity of the electrical stimulation was determined according to the manufacturer's instruction, which uses percentile unit of the maximally allowable electrical energy.
There was no significant difference between the pre-anaesthesia BIS value of the two treatments (90±6 at the second ECT treatment and 91±6 at the third ECT treatment). After anaesthesia, minimum BIS value was 43.5 (range 29-58) at the second ECT treatment and 45.5 (range 26-65) at the third ECT 662 F. NISHIHARA, S. SAITO treatment. BIS scores decreased from the initial values (immediately after the start of recording) after injection of propofol, and then gradually increased from the minimum value.
The pre-ECT BIS value was 48.5 (range 32-65) at the second ECT treatment and 65 (range 50-80) at the third ECT treatment ( Table 1 ). The waiting periods in the third ECT treatment were less than 90 s. During the electrical current application, the BIS monitor indicated "artifact" message showing interference by the electrical stimulation. During the seizure, the monitor further indicated "artifact" message or questionable values. Effect of the muscle relaxant was satisfactory during the seizure in both settings.
Mean blood pressure increased at 1 and 2 minutes after the electrical shock at both settings and there was no significant difference between the two treatments. Heart rate increased at 2 minutes after the electrical shock at both settings and there was no significant difference between the two treatments ( Table 2) .
Muscular seizure duration and EEG seizure duration at the third ECT treatment were significantly longer than those values at second ECT treatment (P<0.01) (Figures 1, 2) . Seizure duration measured by muscle movement was 31±5 s at the second ECT treatment and 46±10 s at the third ECT treatment. The duration measured by EEG was 46±12 s at the second ECT treatment and 63±17 s at the third ECT treatment. No adverse effect was observed throughout this study. No patient reported awareness.
DISCUSSION
BIS scores after administration of 1 mg/kg propofol in this study were comparable to those of previous reports 13, 14 . Although the dose of propofol was determined by body weight, the minimum BIS score after administration ranged from 29 to 74 at the second ECT treatment and 26 to 65 at the third ECT treatment. It is possible that BIS scores were affected by pharmacokinetic variation of patients, such as variation in circulating blood volume or drug clearance, or were affected by variation in sensitivity of the central nervous system. The BIS score immediately before electrical stimulation varied among the patients (range 32-65 at the second ECT treatment and 50-80 at the third ECT treatment). This variation in recovery of BIS scores may be due to differences in pharmacokinetic characteristics, such as drug clearance, among the patients.
In the present study, we obtained 10 to 20% higher HR  85±12  86±15  89±14  101±19*  93±12  90±13  89±13  MAP  89±10  81±15  104±13 †  101±12 †  96±13  96±12  90±12  3rd treatment  HR  84±11  82±11  86±15  105±19*  94±15  91±18  90±21  MAP  90±2  77±14 †  106±16 †  103±14 †  98±12  96±13 BIS values immediately before stimulation in the third ECT treatment compared to the second ECT treatment. As it is technically difficult to obtain exact elevations in the BIS values between treatments, such as a 10% elevation, we considered achieving an elevation in the range of 10 to 20% to be acceptable. We confirmed that the patient with the highest BIS value had previously lost consciousness when his BIS value was 65 to 82% immediately after administration of 1mg/kg of propofol in the 12 ECT treatments, thus indicating a low likelihood of awareness. Seizure duration in the second ECT treatment was comparable to durations seen in previous studies in which 1 mg/kg propofol was used as the anaesthetic 3, 6 . In the present study, we examined patients who had muscular seizure shorter than 40 s in the second ECT treatment, to reduce the risk of prolonged seizure. Although most patients had longer seizures in the third ECT treatment that was performed under higher BIS values, no patients had prolonged seizures or any other adverse effect. Haemodynamic parameters were not adversely affected by waiting for a 10 to 20 higher BIS value. It often happens that seizure duration is gradually reduced when ECT treatments are repeated under an identical conditions 9 . Therefore, the prolonged seizures observed in the third treatment in the present study may be attributable to the difference in anaesthesia depth (as assessed by BIS value). Recent guidelines indicate that seizure duration is not a primary determinant of treatment efficacy. However, extremely short seizures or abortive ones are considered to be ineffective by many psychiatrists. The concept of appropriate seizure duration is not consistent among psychiatrists.
Several approaches have been proposed to control the seizure duration during ECT 1, 9, 15 , such as selection of anaesthetics, dose titration of anaesthetics, manipulation of stimulus intensity, hyperventilation, and use of pro-convulsants. Adjustment of anaesthesia depth by referring to a BIS value may be another option to obtain an appropriate condition for electrical stimulation and to secure satisfactory seizure duration. In the present study, we confirmed that this simple method, waiting for a limited period to obtain a desired BIS value, was effective in prolonging seizure duration and did not induce any adverse effect. This approach may be safer than lowering the dose of anaesthetics because it does not increase the risk of awareness of succinylcholine injection. Waiting for a higher BIS value does increase the risk of awareness of the electrical stimulus. Therefore it is important to ensure that electrical stimulation occurs at a lower BIS value than that observed at the initial loss of consciousness.
In the present study, since we controlled anaesthesia depth by BIS only at the third ECT treatment, we could not assess the psychiatric effect of this technique. Further study is required to determine outcome variables. Ding and White recommend anaesthesia management tailored for each ECT patient to attain an optimal outcome 16 . Adjustment of anaesthesia depth by referring to the BIS value may help develop a better anaesthesia regime for ECT. FIGURE 2: EEG seizure duration and BIS score immediately before electrical stimulation. EEG seizure duration was longer in 19 of 20 subjects. A case where seizure duration in EEG was not increased, was different from the case where muscular seizure duration was not increased in Figure 1 . EEG seizure duration at the 3rd treatment were significantly longer than those values at the 2nd treatment (P<0.01).
